Seborrheic dermatitis

P and T

Volumn 35, Issue 6, 2010, Pages 348-355

  Berk, Thomas ^a   Scheinfeld, Noah ^b,c,d  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Columbia University ^*  (United States)

^c BETH ISRAEL MEDICAL CENTER   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; BECLOMETASONE DIPROPIONATE; BUSPIRONE; BUTENAFINE; CHLORPROMAZINE; CICLOPIROX; CICLOPIROXOLAMINE; CLOTRIMAZOLE; CORTICOSTEROID; FLUCONAZOLE; HALOPERIDOL; HYDROCORTISONE; ITRACONAZOLE; KETOCONAZOLE; LITHIUM CARBONATE; METRONIDAZOLE; PIMECROLIMUS; PYRITHIONE ZINC; SELENIUM SULFIDE; TACROLIMUS; TAR; TEA TREE OIL; TERBINAFINE;

ARTICLE; BURNING SENSATION; CLINICAL FEATURE; CLINICAL TRIAL; CONTACT DERMATITIS; CONTACT SENSITIVITY; CONTROLLED CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; EXFOLIATIVE DERMATITIS; FOLLICULITIS; HUMAN; HYPERPIGMENTATION; HYPOPIGMENTATION; KERATOACANTHOMA; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PHARMACIST; PHOTOTHERAPY; PIGMENTATION; PREVALENCE; PROFESSIONAL PRACTICE; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; SEBORRHEIC DERMATITIS; SIDE EFFECT; SKIN ATROPHY; TELANGIECTASIA; UNSPECIFIED SIDE EFFECT;

EID: 77957164943     PISSN: 10521372     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Plewig G, Janssen T. Seborrheic dermatitis. In: Wolff K, Goldsmith LA, Katz SI, et al., eds. Fitzpatrick's Dermatology in General Medicine, 7th ed. New York: McGraw-Hill; 2008.
2. Gupta AK, Bluhm R. Seborrheic dermatitis. J Eur Acad Dermatol Venereol 2004;18(1):13-26; quiz, 19-20.
3. Johnson, MLT: Skin Conditions and Related Need for Medical Care among Persons 1-74 Years, United States, 1971-1974. Series 11, Data from the National Health Survey. November, No. 212, DHEW Pub No. (PHS) 79-1660. Hyattsville, Md: U.S. Department of Health, Education, and Welfare, Public Health Service, National Center for Health Statistics, 1978.
4. Mahe A, Simon F, Coulibaly S, et al. Predictive value of seborrheic dermatitis and other common dermatoses for HIV infection in Bamako, Mali. J Am Acad Dermatol 1996;34(6):1084-1086.
5. Mallal SA. The Western Australian HIV Cohort Study, Perth, Australia. J Acquir Immune Defic Syndr Hum Retrovirol 1998(17 Suppl 1):S23-S27.
6. Binder RL, Jonelis FJ. Seborrheic dermatitis in neuroleptic-induced parkinsonism. Arch Dermatol 1983;119(6):473-475.
7. Rocha N, Velho G, Horta M, et al. Cutaneous manifestations of familial amyloidotic polyneuropathy. J Eur Acad Dermatol Venereol 2005;19(5):605-607.
8. Ercis M, Balci S, Atakan N. Dermatological manifestations of 71 Down syndrome children admitted to a clinical genetics unit. Clin Genet 1996;50(5):317-320.
9. Gupta AK, Boekhout T, Theelen B, et al. Identification and typing of Malassezia species by amplified fragment length polymorphism and sequence analyses of the internal transcribed spacer and large-subunit regions of ribosomal DNA. J Clin Microbiol 2004;42(9):4253-4260.
10. Tajima M, Sugita T, Nishikawa A, Tsuboi R. Molecular analysis of Malassezia microflora in seborrheic dermatitis patients: Comparison with other diseases and healthy subjects. J Invest Dermatol 2008;128(2):345-351.
11. DeAngelis YM, Gemmer CM, Kaczvinsky JR, et al. Three etiologic facets of dandruff and seborrheic dermatitis: Malassezia fungi, sebaceous lipids, and individual sensitivity. J Investig Dermatol Symp Proc 2005;10(3):295-297.
12. Thomas DS, Ingham E, Bojar RA, Holland KT. In vitro modulation of human keratinocyte pro- and anti-inflammatory cytokine production by the capsule of Malassezia species. FEMS Immunol Med Microbiol 2008;54(2):203-214.
13. Gupta AK, Einarson TR, Summerbell RC, Shear NH. An overview of topical antifungal therapy in dermatomycoses: A North American perspective. Drugs 1998;55(5):645-674.
14. Pierard-Franchimont C, Pierard GE. A double-blind placebocontrolled study of ketoconazole + desonide gel combination in the treatment of facial seborrheic dermatitis. Dermatology 2002; 204(4):344-347.
15. Gupta AK, Nicol K, Batra R. Role of antifungal agents in the treatment of seborrheic dermatitis. Am J Clin Dermatol 2004;5(6): 417-422.
16. Peter RU, Richarz-Barthauer U. Successful treatment and prophylaxis of scalp seborrhoeic dermatitis and dandruff with 2% ketoconazole shampoo: Results of a multicentre, double-blind, placebocontrolled trial. Br J Dermatol 1995;132(3):441-445.
17. Caputo R, Barbareschi M. Itraconazole: New horizons. G Ital Dermatol Venereol 2002;137:1-7.
18. Nahm WK, Orengo I, Rosen T. The antifungal agent butenafine manifests anti-inflammatory activity in vivo. J Am Acad Dermatol 1999;41(2 Part 1):203-206.
19. Abrams BB, Hanel H, Hoehler T. Ciclopirox olamine: A hydroxypyridone antifungal agent. Clin Dermatol 1991;9(4):471-477.
20. Gupta AK. Ciclopirox: An overview. Int J Dermatol 2001;40(5): 305-310.
21. Korting HC, Grundmann-Kollmann M. The hydroxypyridones: A class of antimycotics of its own. Mycoses 1997;40(7-8):243-247.
22. Shuster S, Meynadier J, Kerl H, Nolting S. Treatment and prophylaxis of seborrheic dermatitis of the scalp with antipityrosporal 1% ciclopirox shampoo. Arch Dermatol 2005;141(1):47-52.
23. de Padua CA, Uter W, Geier J, et al. Contact allergy to topical antifungal agents. Allergy 2008;63(7):946-947.
24. Unholzer A, Varigos G, Nicholls D, et al. Ciclopiroxolamine cream for treating seborrheic dermatitis: A double-blind parallel group comparison. Infection 2002;30(6):373-376.
25. Parsad D, Pandhi R, Negi KS, Kumar B. Topical metronidazole in seborrheic dermatitis: A double-blind study. Dermatology 2001;202(1):35-37.
26. Madsen JT, Lorentzen HF, Paulsen E. Contact sensitization to metronidazole from possible occupational exposure. Contact Dermatitis 2009;60(2):117-118.
27. Danby FW, Maddin WS, Margesson LJ, Rosenthal D. A randomized, double-blind, placebo-controlled trial of ketoconazole 2% shampoo versus selenium sulfide 2.5% shampoo in the treatment of moderate to severe dandruff. J Am Acad Dermatol 1993; 29(6):1008-1012.
28. Gillum RF. Hyperpigmentation associated with selenium sulfide lotion. J Natl Med Assoc 1996;88(9):551.
29. Opdyke DL, Burnett CM, Brauer EW. Anti-seborrhoeic qualities of zinc pyrithione in a cream vehicle: II. Safety evaluation. Food Cosmet Toxicol 1967;5(3):321-326.
30. Marks R, Pearse AD, Walker AP. The effects of a shampoo containing zinc pyrithione on the control of dandruff. Br J Dermatol 1985;112(4):415-422.
31. Pierard-Franchimont C, Goffin V, Decroix J, Pierard GE. A multicenter randomized trial of ketoconazole 2% and zinc pyrithione 1% shampoos in severe dandruff and seborrheic dermatitis. Skin Pharmacol Appl Skin Physiol 2002;15(6):434-441.
32. Satchell AC, Saurajen A, Bell C, Barnetson RS. Treatment of dandruff with 5% tea tree oil shampoo. J Am Acad Dermatol 2002; 47(6):852-855.
33. Henley DV, Lipson N, Korach KS, Bloch CA. Prepubertal gynecomastia linked to lavender and tea tree oils. N Engl J Med 2007;356(5):479-485.
34. Hammer KA, Carson CF, Riley TV, Nielsen JB. A review of the toxicity of Melaleuca alternifolia (tea tree) oil. Food Chem Toxicol 2006;44(5):616-625.
35. Josse G, Rouvrais C, Mas A, et al. A multitechnique evaluation of topical corticosteroid treatment. Skin Res Technol 2009;15(1): 35-39.
36. Wikler JR, Nieboer C, Willemze R. Quantitative skin cultures of Pityrosporum yeasts in patients seropositive for the human immunodeficiency virus with and without seborrheic dermatitis. J Am Acad Dermatol 1992;27(1):37-39.
37. Nakagawa H, Etoh T, Ishibashi Y, et al. Tacrolimus ointment for atopic dermatitis. Lancet 1994;344(8926):883.
38. Meshkinpour A, Sun J, Weinstein G. An open pilot study using tacrolimus ointment in the treatment of seborrheic dermatitis. J Am Acad Dermatol 2003;49(1):145-147.
39. Warshaw EM, Wohlhuter RJ, Liu A, et al. Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis. J Am Acad Dermatol 2007;57(2):257-264.
40. Kaposi M. Pathology and treatment of diseases of the skin for practitioners and students [translation, last German edition, under the supervision of James C. Johnston, MD]. New York: William Wood & Co.; 1895.
41. Arnold WP. Tar. Clin Dermatol 1997;15(5):739-744.
42. Wright MC, Hevert F, Rozman T. In vitro comparison of anti-fungal effects of a coal tar gel and a ketoconazole gel on Malassezia furfur. Mycoses 1993;36(5-6):207-210.
43. Lin AN, Moses K. Tar revisited. Int J Dermatol 1985;24(4): 216-218.
44. Lee E, Koo J, Berger T. UVB phototherapy and skin cancer risk: A review of the literature. Int J Dermatol 2005;44(5):355-360.
45. Shin H, Kwon OS, Won CH, et al. Clinical efficacies of topical agents for the treatment of seborrheic dermatitis of the scalp: A comparative study. J Dermatol 2009;36(3):131-137.